Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gabriele Kuntz"'
Autor:
Johanna Engelhard, Tobias P. Dick, Brooke E. Christian, Gabriele Kuntz, Lars Weingarten, Linda L. Spremulli
Publikováno v:
Free radical biologymedicine. 50(10)
Reactive oxygen species (ROS) are released at the mitochondrial inner membrane by the electron transport chain (ETC). Increasing evidence suggests that mitochondrial H2O2 acts as a signaling molecule and participates in the (feedback) regulation of m
Autor:
Takafumi Nakamura, Hermann Einsele, Max S. Topp, Gabriele Kuntz, Horst Hummel, Stephen J. Russell, Axel Greiner
Publikováno v:
The Journal of general virology. 90(Pt 3)
The applicability of cytoreductive treatment of malignant diseases using recombinant viruses strongly depends on specific recognition of surface receptors to target exclusively neoplastic cells. A recently generated monoclonal antibody (mAb), Wue-1,
Autor:
Christian Sinzger, Gabriele Kuntz, Mario Assenmacher, Hermann Einsele, Max S. Topp, Dorothee Wernet, John D.M. Campbell, Georg Rauser
Publikováno v:
Blood. 103(9)
Adoptive transfer of cytomegalovirus (CMV)-specific T cells can restore long-lasting, virus-specific immunity and clear CMV viremia in recipients of allogeneic stem cell transplants if CD4+ and CD8+ CMV-specific T cells are detected in the recipient
Autor:
Jan Diekamm, Gabriele Kuntz, Max S. Topp, Hermann Einsele, Christina Neff, Kai Hauschulz, Olaf Beck, Georg Rauser
Publikováno v:
Blood. 104:4991-4991
Relapse is the leading cause of treatment failure after allogeneic SCT of Hodgkin Disease (HD). As Ebstein-Barr infection (EBV) is associated with 60% of all HD cases, adoptive immunotherapy with donor derived EBV-specific T-cells lines has resulted
Autor:
Gabriele Kuntz, Christian Sinzger, Max S. Topp, Hermann Einsele, Eleni Adamopoulou, Christina Neff, Hans G. Rammensee
Publikováno v:
Molecular Therapy. 9:S212
Adoptive transfer of T-cells expressing herpes simplex thymidine kinase (HSV-TK) induces an immune response against the transgene in HIV patients and in allogeneic stem cell transplant recipients' resulting in eradication of transferred cells. The el
Publikováno v:
Molecular Therapy. 9:S136
Multiple myeloma (MM) is the second most common hematological malignancies with an incidence of 4.1/100.000 per year. Disease control can be achieved by high-dose chemotherapy followed by autologous stem transplantation but relapse occurs in over 90%